Title : Sorafenib inhibits tumor cell growth and angiogenesis in canine transitional cell carcinoma.

Pub. Date : 2022 May 17

PMID : 35387955






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sorafenib is a multi-kinase inhibitor that targets rapidly accelerated fibrosarcoma (RAF), vascular endothelial growth factor receptor (VEGFR)-1, VEGFR-2, VEGFR-3, platelet-derived growth factor receptor-beta (PDGFR-beta), and KIT. Sorafenib KIT proto-oncogene, receptor tyrosine kinase Canis lupus familiaris